Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02343523 · ClinicalTrials.gov registry record
Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 13
- Enrollment target
NCT02343523 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 13 participants.
The verdict
NCT02343523 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The present study proposes to utilize a novel, wearable device, QI Device, which has multiple sensors embedded in a "wrist-watch" in order to explore its monitoring capabilities in individuals with congestive heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02343523
The ClinicalTrials.gov registry entry for NCT02343523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02343523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02343523 about?
NCT02343523 is a clinical study titled "Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure". The present study proposes to utilize a novel, wearable device, QI Device, which has multiple sensors embedded in a "wrist-watch" in order to explore its monitoring capabilities in individuals with congestive heart failure.
What is the current status of trial NCT02343523?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-01. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT02343523?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.